Literature DB >> 19278703

The role of mathematical modelling in malaria elimination and eradication (Comment on: Can malaria be eliminated?).

Richard J Maude, Wirichada Pontavornpinyo, Sompob Saralamba, Arjen M Dondorp, Nicholas P J Day, Nicholas J White, Lisa J White.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19278703      PMCID: PMC2686834          DOI: 10.1016/j.trstmh.2009.01.027

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


× No keyword cloud information.
For many countries, as Professor Greenwood points out, the answer to his question is a resounding ‘yes’. Perhaps the more pertinent question is, with so many more interventions now available, ‘how?’. The two most important new tools that have been added to our malaria control arsenal since the 1950s are artemisinin combination therapies and insecticide-treated bed nets. These are most likely to be effective when used together, in combination with indoor residual spraying where there are suitable vectors. The problem we are faced with is a lack of experience of using such an elimination strategy on a large scale, leading to a lack of data, particularly on the best way to roll out ACTs. In the past, mass screening and treatment, mass drug administration and large-scale replacement of first-line therapies have all been attempted, with varying degrees of success. In the context of newly arisen artemisinin resistance and the diminishing effectiveness of the pyrethroid insecticides, particular care must be taken to preserve the effectiveness of these compounds for as long as possible, whilst achieving maximum impact in a wide variety of epidemiological settings. Another powerful tool that we did not have in the 1950s is sophisticated computer-based mathematical modelling. This facilitates the use of the limited data currently available to make predictions about future events. In other words, it provides a rational framework on which to base decisions made using limited but diverse and complex inter-related information, such as population demographics, pharmacokinetics and pharmacodynamics, treatment-seeking behaviour, spatially distributed risk factors, the presence of antimalarial resistance, etc. Identifying, preparing and calibrating such data sets for each country for the application of mathematical models is a huge challenge in itself. The accuracy of modelling predictions improves in an iterative process as more data become available. Hence, the more intense the malaria elimination efforts are and as long as data are rigorously collected, the more useful and informative modelling becomes. The Bill and Melinda Gates Foundation and others have realized the potential of mathematical modelling to help guide malaria elimination and eradication. Malaria elimination/eradication modelling is still in its infancy (a PubMed search for mathematical modelling papers with the keywords ‘malaria’, ‘elimination’ or ‘eradication’ produced only two articles)3, 4 so these groups have provided significant funding to focus modelling efforts on this problem. Professor Greenwood states that new tools are likely to be required in order to eliminate malaria in high-transmission areas. If, eventually, we do have the luxury of an effective malaria vaccine or powerful new gametocytocidal drugs they are likely to be expensive and their scale-up will inevitably be based on limited trial data in the initial stages. Mathematical modelling will be indispensible in helping to maximize their impact.

Funding

Mahidol-Oxford Tropical Medicine Research Unit is funded by the Wellcome Trust of Great Britain.

Conflicts of interest

None declared.

Ethical approval

Not required.
  3 in total

1.  The malaria Atlas Project: developing global maps of malaria risk.

Authors:  Simon I Hay; Robert W Snow
Journal:  PLoS Med       Date:  2006-12       Impact factor: 11.069

2.  Prospects for malaria eradication in sub-Saharan Africa.

Authors:  Ricardo Aguas; Lisa J White; Robert W Snow; M Gabriela M Gomes
Journal:  PLoS One       Date:  2008-03-12       Impact factor: 3.240

3.  Modelling the impact of artemisinin combination therapy and long-acting treatments on malaria transmission intensity.

Authors:  Lucy C Okell; Chris J Drakeley; Teun Bousema; Christopher J M Whitty; Azra C Ghani
Journal:  PLoS Med       Date:  2008-11-25       Impact factor: 11.069

  3 in total
  6 in total

Review 1.  Artemisinin resistance: current status and scenarios for containment.

Authors:  Arjen M Dondorp; Shunmay Yeung; Lisa White; Chea Nguon; Nicholas P J Day; Duong Socheat; Lorenz von Seidlein
Journal:  Nat Rev Microbiol       Date:  2010-03-08       Impact factor: 60.633

2.  The role of mathematical modelling in guiding the science and economics of malaria elimination.

Authors:  Richard J Maude; Yoel Lubell; Duong Socheat; Shunmay Yeung; Sompob Saralamba; Wirichada Pongtavornpinyo; Ben S Cooper; Arjen M Dondorp; Nicholas J White; Lisa J White
Journal:  Int Health       Date:  2010-12       Impact factor: 2.473

3.  Artemisinin Antimalarials: Preserving the "Magic Bullet"

Authors:  Richard J Maude; Charles J Woodrow; Lisa J White
Journal:  Drug Dev Res       Date:  2010-02       Impact factor: 4.360

4.  The role of simple mathematical models in malaria elimination strategy design.

Authors:  Lisa J White; Richard J Maude; Wirichada Pongtavornpinyo; Sompob Saralamba; Ricardo Aguas; Thierry Van Effelterre; Nicholas P J Day; Nicholas J White
Journal:  Malar J       Date:  2009-09-14       Impact factor: 2.979

5.  The last man standing is the most resistant: eliminating artemisinin-resistant malaria in Cambodia.

Authors:  Richard J Maude; Wirichada Pontavornpinyo; Sompob Saralamba; Ricardo Aguas; Shunmay Yeung; Arjen M Dondorp; Nicholas P J Day; Nicholas J White; Lisa J White
Journal:  Malar J       Date:  2009-02-20       Impact factor: 2.979

6.  Local scale prediction of Plasmodium falciparum malaria transmission in an endemic region using temperature and rainfall.

Authors:  Yazoumé Yé; Moshe Hoshen; Catherine Kyobutungi; Valérie R Louis; Rainer Sauerborn
Journal:  Glob Health Action       Date:  2009-11-11       Impact factor: 2.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.